Gilead Sciences (GILD) EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, bln rub | ? | 4 133 | 11 329 | 6 775 | 8 852 | 10 496 | 139.0 | ||
Changes by years, y/y, % | -45% | +174% | -40% | +31% | +19% | +3.4% |
Gilead Sciences. EBITDA US GAAP, bln rub
Gilead Sciences. EBITDA US GAAP, changes, %
Gilead Sciences. EBITDA US GAAP, sum by quarters, bln rub
Gilead Sciences (GILD) EBITDA US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
EBITDA, bln rub | ? | 3 109 | -3 541 | 2 983 | -191.0 | 888.0 | 139.0 | |
Changes by years, y/y, % | +55% | -276% | +45% | -106% | -73% | |||
Changes by quarters, q/q, % | +20% | -214% | -184% | -106% | -565% |